Common adverse effects of Wegovy predominantly involve the gastrointestinal system and include nausea, vomiting, diarrhoea, constipation, and abdominal discomfort
Patients requiring multifactorial risk management : Individuals with multiple cardiovascular risk factors may benefit from the pleiotropic effects of GLP-1 therapy, including blood pressure reduction, weight loss, and lipid improvements
2.10.2 PPARs The three subtypes of PPARsPPAR-, PPAR-/, and PPAR-hold potential as therapeutic targets for combating atherosclerosis ( / FXR / mouse model by promoting -oxidation of fatty acids and increasing liver to absorb fatty acids from plasma
TanousDRRuedlGKirschnerWDrenowatzCCraddockJRosemannTet al
(: Glutathione) (GSH) (L-cysteine, glycine, and L-glutamate)